Corpus Intelligence IC Memo — SISKIN HOSPITAL FOR PHYSICAL REHABIL 2026-04-26 09:37 UTC
IC Memo — SISKIN HOSPITAL FOR PHYSICAL REHABIL
Investment Committee Memorandum | TN | 96 beds | Grade D | EBITDA uplift $3.6M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

SISKIN HOSPITAL FOR PHYSICAL REHABIL

CCN 443025 | HAMILTON, TN | 96 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

SISKIN HOSPITAL FOR PHYSICAL REHABIL is a 96-bed community hospital in HAMILTON, TN with $48.9M in net patient revenue and a -2.4% operating margin. The hospital serves a payer mix of 45.6% Medicare, 0.0% Medicaid, and 54.4% commercial.

Thesis: Turnaround. Our ML models identify $3.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -2.4% to 4.9% (+736bps).

Net Revenue HCRIS$48.9M
Current EBITDA COMPUTED$-1.2M
Operating Margin COMPUTED-2.4%
Occupancy HCRIS80.7%
Revenue / Bed COMPUTED$509K
Net-to-Gross HCRIS79.1%
Distress Probability MLnan%

2. Market Context & Competitive Position

141
TN Hospitals
-0.6%
State Median Margin
55
Comparable Hospitals

TN has 141 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of -2.4% places it below the state median. Among 55 size-comparable peers (48-192 beds), the median margin is 2.1%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (48-192), prioritizing same-state peers. 55 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SISKIN HOSPITAL FOR PHYSICAL R (Target)TN96$48.9M-2.4%
BLOUNT MEMORIAL HOSPITALTN145$326.0M-8.5%
SUMMIT MEDICAL CENTERTN188$298.0M40.6%
METRO NASHVILLE GENERAL HOSPITTN114$287.4M48.9%
TRISTAR HENDERSONVILLE MEDICALTN129$208.6M41.5%
TRISTAR STONECREST MEDICAL CENTN115$190.0M39.5%
BAPTIST MEM HOSPITAL TIPTON COTN48$179.0M-5.8%
SKYRIDGE MEDICAL CENTERTN176$163.5M17.3%
SUMNER REGIONAL MEDICAL CENTERTN138$161.9M-2.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.0M+210bp18mo
Cost to Collect4.5%2.5%$977K+200bp12mo
Denial Rate Reduction12.0%6.5%$968K+198bp12mo
A/R Days Reduction5200.0%3800.0%$595K+122bp9mo
Clean Claim Rate88.0%96.0%$31K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.0M
Cost to Collect
$977K
Denial Rate Reduction
$968K
A/R Days Reduction
$595K
Clean Claim Rate
$31K
Total EBITDA Uplift$3.6M
Current EBITDA$-1.2M
+ RCM Uplift+$3.6M
Pro Forma EBITDA$2.4M
Current Margin-2.4%
Pro Forma Margin4.9%
WC Released (1x)$1.9M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-1.8M$28.1M0.00x-100.0%
Base (11x exit)10.0x11.0x$-1.8M$30.3M0.00x-100.0%
Bull Case9.0x11.0x$-1.7M$41.6M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-1.7M$44.9M0.00x-100.0%
Bear Case11.0x10.0x$-2.0M$10.7M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-2.0M$11.1M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 55 hospitals with 48-192 beds
  • Same-state prioritization (n=56)
  • Comp margins: P25=-8.3% / P50=2.1% / P75=14.6%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.